` API (Australian Pharmaceutical Industries Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

API
vs
S&P/ASX 300

Over the past 12 months, API has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's 10% growth.

Stocks Performance
API vs S&P/ASX 300

Loading
API
S&P/ASX 300
Add Stock

Performance Gap
API vs S&P/ASX 300

Performance Gap Between API and AXKO
HIDDEN
Show

Performance By Year
API vs S&P/ASX 300

Loading
API
S&P/ASX 300
Add Stock

Competitors Performance
Australian Pharmaceutical Industries Ltd vs Peers

S&P/ASX 300
API
MCK
0HF3
COR
CAH
Add Stock

Australian Pharmaceutical Industries Ltd
Glance View

Market Cap
753.8m AUD
Industry
Health Care

Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.

API Intrinsic Value
Not Available
Back to Top